Milestone Pharmaceuticals names David Sandoval general counsel Feb 10, 2026 08:03AM
Milestone's CARDAMYST nasal spray now available at U.S. pharmacies Jan 26, 2026 08:02AM
Milestone Pharmaceuticals receives $75 million from RTW for etripamil royalties Jan 13, 2026 06:09AM
European regulators accept Milestone's etripamil application for heart condition Jan 6, 2026 08:02AM
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026 Dec 21, 2025 04:00AM


Dec 17, 2025 05:00PM Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Dec 15, 2025 10:22AM Increasing unusual option volume: MIST APPN NXDR IRBT XPO FLWS ENTG FBIO FND
Dec 15, 2025 10:03AM TD Cowen Upgrades Milestone Pharmaceuticals (MIST) to Buy
Dec 15, 2025 09:48AM Milestone Pharmaceuticals (MIST) PT Raised to $8 at H.C. Wainwright
Dec 15, 2025 05:05AM Increasing unusual call option volume: CMA OCSL CVE NXDR SHOO LDOS RCUS MIST
Nov 13, 2025 04:31AM Milestone Pharmaceuticals (MIST) PT Raised to $2 at Jefferies
Nov 12, 2025 07:09AM Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 4c
Sep 11, 2025 05:28AM Wells Fargo Starts Milestone Pharmaceuticals (MIST) at Overweight
Jul 11, 2025 09:32AM Milestone Pharmaceuticals prices $52.5 million public offering
Jul 11, 2025 06:02AM Milestone Pharmaceuticals announces public offering of shares and warrants
Jul 11, 2025 06:00AM Milestone Pharmaceuticals receives FDA acceptance for CARDAMYST response
Jun 17, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Jun 16, 2025 08:03AM Milestone Pharmaceuticals Inc. (MIST) Submits Response to the FDA’s CRL for CARDAMYST
May 14, 2025 04:26PM Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 11c
Apr 1, 2025 06:13AM TD Cowen Downgrades Milestone Pharmaceuticals (MIST) to Hold
Mar 28, 2025 07:00AM Milestone Pharmaceuticals (MIST): FDA Issues Complete Response Letter for Etripamil for PSVT
Mar 28, 2025 06:57AM Milestone Pharmaceuticals Inc. (MIST) Halted, News Pending
Mar 18, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Mar 17, 2025 09:48AM Increasing unusual option volume: COMM MIST HNRG VERU QFIN
Mar 13, 2025 04:38PM Milestone Pharmaceuticals Inc. (MIST) Misses Q4 EPS by 3c
Feb 19, 2025 08:01AM Milestone Pharmaceuticals (MIST) Notice of Allowance on New U.S. Patent for Etripamil
Jan 28, 2025 08:04AM Milestone Pharmaceuticals (MIST) Provides 2025 Corporate Outlook and Will Host Investor Event on February 25 in NYC
Jan 27, 2025 07:23AM H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Nov 12, 2024 05:20PM Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 2c
Oct 21, 2024 08:42AM TD Cowen Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Oct 14, 2024 07:23AM H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Sep 9, 2024 08:45AM TD Cowen Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)
Sep 6, 2024 07:01AM Milestone (MIST) Partner Ji Xing Pharmaceuticals Reports Positive Topline Results from the Phase 3 Study of Etripamil in PSVT in China
Sep 4, 2024 08:03AM Milestone Pharmaceuticals Inc. (MIST) Appoints Joseph Papa to its Board
Aug 9, 2024 06:26AM Milestone Pharmaceuticals Inc. (MIST) Tops Q2 EPS by 5c
Jul 15, 2024 08:02AM Milestone Pharmaceuticals Inc. (MIST) Announces Board Changes
Jul 2, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Milestone Pharmaceuticals (MIST)